A Missouri jury ruled in favor of Abbott and Reckitt’s Mead Johnson on Thursday, determining that the companies were not responsible for a young boy’s intestinal disease. The lawsuit, filed by Elizabeth Whitfield on behalf of her son Kaine, claimed the companies failed to warn about the risks of their premature baby formulas, alleging they caused Kaine to develop necrotizing enterocolitis (NEC), a life-threatening condition. Despite Whitfield's lawyers urging more than $6 billion in damages, the jury sided with the companies. This ruling marks a victory after several losses in similar cases, including past verdicts of $60 million against Mead Johnson and $495 million against Abbott. Following the decision, Reckitt’s shares surged by 11.7%, and Abbott saw nearly a 5% increase in pre-market trading.
The jury found the claims lacked scientific support, with Abbott and Mead Johnson maintaining their formulas do not cause NEC. The companies referenced studies and statements from U.S. regulatory agencies that concluded there was no clear link between formula and the disease, though these were not allowed in court. This case is part of over 1,000 similar lawsuits, raising concerns about the availability of formulas and medical decisions. Abbott and Mead Johnson have argued that while human milk offers protection against NEC, their products are not responsible for the condition. This decision may influence future cases and settlement talks.
